Key Financial Metrics:
- Q4 revenue: $619 million, a 5% year-over-year increase
- Fourth quarter consumable revenue represented 66% of total revenue, or $407 million, an 18% increase compared to the fourth quarter of 2015
- Sequencing consumable revenue grew 20% year-over-year to $331 million
- Services and other revenue equaled $94 million
- Adjusted gross margin for the fourth quarter was 69.9%
- Adjusted research and development expenses in Q4 were $121 million, or 19.5% of revenue
- Adjusted SG&A expenses for the quarter equaled $130 million, or 20.9% of revenue
- Operating margin was 29.5%, compared to 34.4% in the third quarter
- Stock-based compensation expense equaled $27 million
- Fourth quarter GAAP net income: $124 million and EPS of $0.84 per diluted share
- Non-GAAP net income: $126 million or $0.85 of EPS
- Cash flow from operations equaled $280 million
- Capital expenditures in Q4 were $82 million
- Q4 free cash flow was $199 million
- Ended the quarter with approximately $1.6 billion in cash and short-term investments
- Repurchased 1 million shares under previously announced buyback programs at an average price of $129
- Projecting Q1 revenue of $580 million to $595 million
- Total company revenue expected to grow 10% to 12% in 2017
- Cash flow from operations equaled $280 million
- Q4 free cash flow was $199 million
- Ended the quarter with approximately $1.6 billion in cash and short-term investments
- Projecting Q1 revenue of $580 million to $595 million
- Total company revenue expected to grow 10% to 12% in 2017